Cargando…
Universal Screening of Gastrointestinal Malignancies for Mismatch Repair Deficiency at Stanford
BACKGROUND: In light of recent Food and Drug Administration (FDA) approval of immune checkpoint inhibitors for mismatch repair deficient (dMMR) malignancies, identifying patients with dMMR malignancies has become increasingly important. Although screening for dMMR in colorectal cancer (CRC) is recom...
Autores principales: | Abrha, Aser, Shukla, Navika D, Hodan, Rachel, Longacre, Teri, Raghavan, Shyam, Pritchard, Colin C, Fisher, George, Ford, James, Haraldsdottir, Sigurdis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667994/ https://www.ncbi.nlm.nih.gov/pubmed/33225206 http://dx.doi.org/10.1093/jncics/pkaa054 |
Ejemplares similares
-
Prevalence of Lynch syndrome in women with mismatch repair‐deficient ovarian cancer
por: Hodan, Rachel, et al.
Publicado: (2020) -
Controversies and management of deficient mismatch repair gastrointestinal cancers in the neoadjuvant setting
por: Boutin, Mélina, et al.
Publicado: (2023) -
Mismatch repair deficiency may be common in ductal adenocarcinoma of the prostate
por: Schweizer, Michael T., et al.
Publicado: (2016) -
Germline Testing for Patients With BRCA1/2 Mutations on Somatic Tumor Testing
por: Vlessis, Katherine, et al.
Publicado: (2019) -
Mixed lineage kinase 3 gene mutations in mismatch repair deficient gastrointestinal tumours
por: Velho, Sérgia, et al.
Publicado: (2010)